MEDIA & PRESS UPDATES
NEW GRANT FROM THE SWISS INNOVATION AGENCY
June 1, 2020
Our hand-santizer project "Disigel" is receiving further support from the Swiss Innovation Agency (Innosuisse). Together with the Swiss Federal Laboratories for Materials Science and Technology (EMPA) and the SPIEZ LABORATORY, we will further develop and test the safety and efficacy against Sars-CoV-2.
LUMENDO RECEIVES SUPPORT FROM THE GEBERT RÜF STIFTUNG
April 15, 2020
To help fighting the global Covid-19 pandemic, Lumendo received support from the Gebert Rüf Stiftung to develop a revolutionary, long-lasting hand sanitizer "Disigel". Find out more in the project description and the press release.
SHAPING THE PROFESSIONALS OF TOMORROW
10 September 2019
A school class from the Liceo Artistico Zurich visited our R&D department and labs. The pupils learned about the fascinating world of light-curing materials and could try out our prototypes themselves in the lab.
BRIDGING THE RESEARCH FUNDS
Lumendo CTO and co-founder Mark Bispinghoff is awarded the SNF BRIDGE "Proof of concept" grant for the project “Photopolymerizable, stable hydrogels for medical applications”.
AGEFI SPEAKS ABOUT US
Lumendo is in the news: Lumendo is mentioned by AGEFI, Société de l’Agence Economique et Financière S.A. related to the nomination of PERL (Prix Entreprendre Lausanne Région).
SELECTED AS VENTURE LEADER LIFE SCIENCE 2017
Lumendo CEO and co-founder Andreas Schmocker is selected as a Venture Leader Life Science 2017. This enables him to travel to Boston as part of the Swiss National Startup Team to explore the US startup scene and the US dental and medical device market.
ETH PIONEER FELLOWSHIP AWARDED
Lumendo CTO and co-founder Mark Bispinghoff is awarded the ETH Pioneer Fellowship to turn his PhD research into a commercial product. ETH Zürich and the ETH Zürich foundation grants financial support and free lab and office space.